Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 498
Summary
- Conditions
- Antineoplastic Agents
- Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)
- Cardiotoxicity
- Elderly
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Randomized, multicenter, open-label clinical trial comparing, in elderly patient with cancer under anti-tumoral treatment, two different cardiotoxicity prevention strategiesMasking: None (Open Label)Primary Purpose: Prevention
Participation Requirements
- Age
- Between 65 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03711110
- Collaborators
- Instituto de Investigación Biomédica de Salamanca
- Instituto de Salud Carlos III
- Investigators
- Study Director: Pedro L Sánchez, Ph. D. IBSAL-Instituto de Investigación Biomédica de Salamanca Study Director: Ana Martín-García, Ph. D. IBSAL-Instituto de Investigación Biomédica de Salamanca